Assessment of performance characteristics of COVID-19 ICD-10-CM diagnosis code U07.1 using SARS-CoV-2 nucleic acid amplification test results.

Assessment of performance characteristics of COVID-19 ICD-10-CM diagnosis code U07.1 using SARS-CoV-2 nucleic acid amplification test results.

The Food and Drug Administration's Biologics Effectiveness and Safety Initiative conducts active surveillance to protect public health during the coronavirus disease 2019 (COVID-19) pandemic. This study evaluated performance of International Classification of Diseases, Tenth Revision, Clinical...

Full description

Bibliographic Details
Main Authors: Keran Moll, Shayan Hobbi, Cindy Ke Zhou, Kathryn Fingar, Timothy Burrell, Veronica Hernandez-Medina, Joyce Obidi, Nader Alawar, Steven A Anderson, Hui-Lee Wong, Azadeh Shoaibi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0273196

Internet

https://doi.org/10.1371/journal.pone.0273196

Similar Items